- Round ID
- FR-00220
- Stage
- Series B
- Round name
- Series B
- Amount
- £35.5M
Dated funding evidence
Evox Therapeutics
Series B · £35.5M · 2018-09-01
Reported round£35.5MSeries B
- Disclosure date
- 2018-09-01
- Reported currency
- GBP
- Companies House
- 10076821
- Evidence sources
- 1
Company
Evox TherapeuticsCH 100768212018-09-01Series B£35.5M
Resolved investor records
No named investor resolved to an exact canonical investor record.
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Not stated
- Other investors
- Not stated
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.